Crossmark

Predictive factors of clinically significant drug–drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir

Crossref DOI link: https://doi.org/10.1016/j.medcle.2016.06.015

Published Print: 2016-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cervero, Miguel

Torres, Rafael

Jusdado, Juan José

Pastor, Susana

Agud, Jose Luis
License Information

Text and Data Mining valid from 2016-04-01
More Information

This article is maintained by: Elsevier

Article Title: Predictive factors of clinically significant drug–drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2016.06.015

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2016.01.016

Content Type: article

Copyright: © 2016 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below